Trial Profile
A post-approval safety study of Gimoti in comparison with Reglan oral tablet
Status:
Planning
Phase of Trial:
Phase IV
Latest Information Update: 20 Feb 2018
Price :
$35
*
At a glance
- Drugs Metoclopramide (Primary) ; Metoclopramide (Primary)
- Indications Diabetic gastroparesis
- Focus Adverse reactions
- 20 Feb 2018 New trial record
- 15 Feb 2018 According to an Evoke Pharma media release, the company is planning discuss the details of this trial with FDA during the NDA review process